Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

Recruiting

LemborexantLemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

Sponsor:

Nova Scotia Health Authority

Code:

NCT06093126

Conditions

Insomnia

Dementia

Frontotemporal Dementia

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Lemborexant 5 MG

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-18. This information was provided to ClinicalTrials.gov by Nova Scotia Health Authority on 2025-02-21.